Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05934396 · ClinicalTrials.gov registry record · NA
Practice Experiences for School Reintegration
A NA study of Suicide, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT05934396: Completed NA study of Suicide, sponsored by University of North Carolina, Chapel Hill.
NCT05934396 is a NA study of Suicide that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 54 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05934396, a NA study of Suicide, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is developing and refining a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR will provide immersive school experiences for inpatient adolescents (with suicidal-related admissions) to practice skills in real-world settings with the guidance of a trained clinician within the confines of a hospital. This pilot study follows a Multiphase Optimization Strategy (MOST) to conduct a pilot optimization trial of the PrESR to inform the feasibility of training clinicians, the ability to recruit adolescent inpatient participants, and management of experimental conditions. This study is not powered to test hypotheses; however, in addition to assessing feasibility and acceptability, this pilot trial will assess candidate intermediary and outcome measures.
Primary Outcome
Recruitment rate was determined based on the proportion of adolescents providing assent and parents or legal guardians providing permission relative to the number of parents or legal guardians approached.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT) Worksheets
- BEHAVIORAL Safety Planning
- BEHAVIORAL VR Enhanced Affect Regulation
- BEHAVIORAL VR Enhanced Cognitive Restructuring
- BEHAVIORAL VR Enhanced Problem Solving
Study Locations (1)
North Carolina
- UNC Adolescent Psychiatry Inpatient Unit - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
What the finished NCT05934396 record still lists
NCT05934396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 5 interventions - of which Cognitive Behavioral Therapy (CBT) Worksheets is the first listed.
NCT05934396 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05934396 about?
NCT05934396 is a clinical study titled "Practice Experiences for School Reintegration". This study is developing and refining a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR will provide immersive school experiences for inpatient adolescents (with suicidal-related admissions) to practice skill...
What is the current status of trial NCT05934396?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2023-08-01. Estimated completion is 2024-12-20.
What conditions does trial NCT05934396 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05934396?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) Worksheets (BEHAVIORAL), Safety Planning (BEHAVIORAL), VR Enhanced Affect Regulation (BEHAVIORAL), VR Enhanced Cognitive Restructuring (BEHAVIORAL), VR Enhanced Problem Solving (BEHAVIORAL).
Who is sponsoring clinical trial NCT05934396?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05934396 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05934396's enrollment target sits among peer trials
54 71st of 92 higher than 22 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI